IP Library Granted Patent US 8,765,059
Granted Patent B2
US 8,765,059 · App. 12/913,559 · Granted Jul 1, 2014

Blood glucose tracking apparatus

Inventors: Steven Drucker (Oakland, CA); Charles T. Liamos (Pleasanton, CA); Fredric C. Colman (Woodside, CA); Mark Lortz (San Francisco, CA); Kelley Lipman (Livermore, CA); Feng Jiang (Union City, CA); Henrik Bacho (San Francisco, CA)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,059
App. No.
12/913,559
Granted
Jul 1, 2014
Kind
B2
Abstract

A measurement module for glucose testing includes a glucose testing measurement module housing, a test strip receptacle formed in the housing, and a connector portion formed in the housing and shaped to permit mechanical removable attachment of the housing to a hand-held computer. Electronics determine the amount of glucose present in a sample of body fluid, when the test strip is positioned in the receptacle and the body fluid is placed on a test strip, and communicate the glucose amount to the hand-held computer via the connector portion.

Claims (55)

1. A diabetes management system, comprising:

a device having

a housing,

an input interface, and

a processing circuit coupled to the input interface; and

a measurement module electrically coupled to the device, wherein the measurement module includes

a measurement module housing,

a processor,

a non-transitory computer readable medium programmed with instructions that cause the processor to:

(a) communicate processor-executable setup software instructions to the processing circuit of the device; and

(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,

a test strip receptacle formed at a first side of the measurement module housing,

electronics for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle, and

a connector portion at a second side of the measurement module housing for electrically coupling to the input interface of the device and for transmitting the processor-executable setup instructions and data corresponding to the amount of glucose present in the sample of blood to the device.

2. The diabetes management system of claim 1 , wherein a first end of the measurement module housing is narrower than a second end of the measurement module housing.

3. The diabetes management system of claim 1 , wherein the measurement module housing has a rounded profile, and wherein the rounded profile of the measurement module housing is curved in two or more directions.

4. The diabetes management system of claim 1 , wherein a first end of the measurement module housing has a trapezoidal profile.

5. The diabetes management system of claim 4 , wherein the trapezoidal profile results in the first end of the measurement module housing being narrower than a second end of the measurement module housing.

6. The diabetes management system of claim 1 , wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.

7. The diabetes management system of claim 1 , wherein the system includes only a single display provided in the housing.

8. The diabetes management system of claim 1 , wherein the device can process the data received from the measurement module, whether or not the measurement module is integrated with the device.

9. A diabetes management system, comprising:

a device having

a housing,

an input interface, and

a processing circuit coupled to the input interface; and

a detachable measurement module electrically coupled to the device, wherein the measurement module includes

a measurement module housing,

a processor,

a non-transitory computer readable medium programmed with instructions that cause the processor to:

(a) communicate processor-executable setup software instructions to the processing circuit of the device; and

(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,

a test strip receptacle,

electronics for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle, and

a connector portion for electrically coupling to the input interface of the device and transmitting the processor-executable setup instructions to the device.

10. The diabetes management system of claim 9 , wherein a first end of the measurement module housing is narrower than a second end of the measurement module housing.

11. The diabetes management system of claim 9 , wherein the measurement module housing is rounded in two or more directions.

12. The diabetes management system of claim 9 , wherein a trapezoidal profile is provided in a first end of the measurement module housing.

13. The diabetes management system of claim 9 , wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.

14. The diabetes management system of claim 9 , wherein the system includes only a single display provided in the housing.

15. The diabetes management system of claim 9 , wherein the device can process the data received from the measurement module, whether or not the measurement module is integrated with device.

16. A measurement module for detachable integration with a device, the measurement module comprising:

a housing;

a test strip receptacle formed in the housing;

electronics disposed within the housing for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle;

a processor,

a non-transitory computer readable medium programmed with instructions that cause the processor to:

(a) communicate processor-executable setup software instructions to the processing circuit of the device; and

(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,

a connector portion formed in the housing for insertion into a receptacle formed in the device, wherein the connector portion provides electrical coupling to the device to transmit the processor-executable setup instructions and data corresponding to the amount of glucose present in the sample of blood.

17. The measurement module of claim 16 , wherein the test strip receptacle is provided at a first end of the housing.

18. The measurement module of claim 16 , wherein the housing is rounded in two or more directions.

19. The diabetes management system of claim 16 , wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.

20. The diabetes management system of claim 1 , wherein the measurement module is powered by the device.

21. The diabetes management system of claim 9 , wherein the measurement module is powered by the device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2010
From: DRUCKER, STEVEN; LIAMOS, CHARLES T.; COLMAN, FREDRIC; LORTZ, MARK; LIPMAN, KELLEY; JIANG, FENG; BACHO, HENRIK
To: THERASENSE INC.
Reel/Frame 025403/0106 →
CHANGE OF NAME Recorded Nov 30, 2010
From: THERASENSE INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 025414/0395 →
Continuity (5)
Continuation 11160407 · Jun 22, 2005
Continuation 10112671 · Mar 29, 2002
Provisional Application 60300011 · Jun 20, 2001
Provisional Application 60280905 · Apr 2, 2001
Related Publication 20110038765A1 · Feb 17, 2011